Teva completes deal for second migraine-treatment developer
July 21, 2014 at 12:39 PM EDT
Teva Pharmaceutical Industries Ltd. completed its previously announced acquisition of Labrys in a deal that strengthens the generic and branded pharmaceutical company’s presence in the migraine headache treatment and central nervous system disorder arena...